CAJ | 학술논문

　　在药品降价、药品价格调查与管控、抗菌药物临床应用专项整治及基药招标“唯低价论”等一系列政策组合拳的大环境下，国内抗生素行业遭遇巨大挑战。抗生素市场快速增长态势戛然而止，2011年跌幅1.97%，2012年跌幅加大近一个百分点达2.86%，同期医院用药整体市场增幅超过20%。医院用药金额前20个药品中抗生素品种数量从2011年的6个退减至2012年的3个。以抗生素为主的上市公司经济指标大幅滑落，自身战略性调整、顺应政策导向及提升运营质量对企业的未来生存和发展至关重要。
　　재약품강개、약품개격조사여관공、항균약물림상응용전항정치급기약초표“유저개론”등일계렬정책조합권적대배경하，국내항생소행업조우거대도전。항생소시장쾌속증장태세알연이지，2011년질폭1.97%，2012년질폭가대근일개백분점체2.86%，동기의원용약정체시장증폭초과20%。의원용약금액전20개약품중항생소품충수량종2011년적6개퇴감지2012년적3개。이항생소위주적상시공사경제지표대폭활락，자신전략성조정、순응정책도향급제승운영질량대기업적미래생존화발전지관중요。
In the circumstance of series policy portfolio of the reduction, survey and control of drug price, the special management of the clinical application of antibacterial agents and the“only cheap theory”in the bidding of essential medicines, the domestic antibiotics industry has suffered enormous challenges. The rapid growth of antibiotic market has been halted, and sales were declined from 1.97%in 2011 to 2.86%in 2012, but the hospital medication increased over 20%at same time. The number of antibiotics varieties in top twenty hospital medication decreased from six in 2011 to three in 2013. The economic indicators of the listed companies based on the production of antibiotics fell sharply. It is more important to adjust own strategic, obey the policy direction and promote the quality of operations so as to enhance the company’s survival and development in the future.